physodic acid has been researched along with Prostatic Neoplasms in 1 studies
*Prostatic Neoplasms: Tumors or cancer of the PROSTATE. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avola, R; Cardile, V; Graziano, ACE; Madrid, A; Russo, A | 1 |
1 other study(ies) available for physodic acid and Prostatic Neoplasms
| Article | Year |
|---|---|
Physodic acid sensitizes LNCaP prostate cancer cells to TRAIL-induced apoptosis.
Topics: Apoptosis; Cell Line, Tumor; Dibenzoxepins; Humans; Male; Prostatic Neoplasms; TNF-Related Apoptosis-Inducing Ligand | 2022 |